Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 63Terminated 17Unknown 11Recruiting 9Suspended 2Not yet recruiting 2No longer available 1Active not recruiting 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Conditions

Neoplasms 18Breast Neoplasms 9Prostatic Neoplasms 8Melanoma 8Colorectal Neoplasms 8Carcinoma, Non-Small-Cell Lung 7Pancreatic Neoplasms 6Neoplasm Metastasis 6Ovarian Neoplasms 5Carcinoma, Hepatocellular 5Triple Negative Breast Neoplasms 4Myelodysplastic Syndromes 4Leukemia, Myeloid, Acute 4Glioblastoma 4Carcinoma, Renal Cell 4Stomach Neoplasms 3Solid Tumors 3Multiple Myeloma 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Leukemia 3Uterine Cervical Neoplasms 2Small Cell Lung Carcinoma 2Sarcoma 2Recurrence 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Pain 2Mesothelioma 2Lymphoma, T-Cell 2Liver Neoplasms 2

Interventions

Ifosfamide 1Amblyomin-X protein, Amblyomma cajennense 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × INDUSTRY × Advanced Cancer × Clear all
NCT03120130 2019-10-14

Amblyomin-X

União Química Farmacêutica Nacional S/A

Phase 1 Suspended
24 enrolled

Advanced Cancer

NCT00607711 2008-05-05

Study of Oral Palifosfamide Tris in Solid Tumors

Alaunos Therapeutics

Phase 1 Suspended
20 enrolled

Advanced Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡